Findings

What do systematic reviews say?

107 questions · 108 findings · 7 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 30 · 27.8%GRADE not reported 6 · 5.6%Very low 15 · 13.9%Low 41 · 38%Moderate 12 · 11.1%High 4 · 3.7%

Desloratadine 5 to 20 mg vs placebo

Complete suppression of urticaria: short‐term duration of intervention (desloratadine 5 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Low

Desloratadine 5 to 20 mg vs placebo

Complete suppression of urticaria: short‐term duration of intervention (desloratadine 10 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Low

Desloratadine 5 to 20 mg vs placebo

Complete suppression of urticaria: short‐term duration of intervention (desloratadine 20 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 46 participants
Low

Desloratadine 5 to 20 mg vs placebo

Complete suppression of urticaria: intermediate‐term duration of intervention (desloratadine 5 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 80 participants
Low

Desloratadine 5 to 20 mg vs placebo

Adverse effects requiring withdrawal/discontinuation of study medication · patients with chronic spontaneous urticaria

Desloratadine 5 to 20 mg showed no clear difference in adverse effects leading to withdrawal: intermediate‐term duration of… compared with placebo (low certainty).

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
RR 1.46 [0.42, 5.1]
3 studies · 466 participants
Low

Levocetirizine 5 to 20 mg vs placebo

Complete suppression of urticaria: short‐term duration of intervention (levocetirizine 5 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Low

Levocetirizine 5 to 20 mg vs placebo

Complete suppression of urticaria: short‐term duration of intervention (levocetirizine 10 mg) Global assessment of symptom scores · patients with chronic spontaneous urticaria

1 finding from 1 review

H1‐antihistamines for chronic spontaneous urticaria 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 49 participants
Low